Preview

Problems of Endocrinology

Advanced search

Insulin pump therapy with the function of automatic stopping delivery of insulin in response to hypoglycemia

https://doi.org/10.14341/probl201258370-74

Abstract

The advent of the new insulin pump with the function of automatic stopping delivery of insulin in response to hypoglycemia marks a new stage in the development of closed-loop devices for insulin administration. This review is devoted to insulin pump therapy with the use of this function. The results obtained up to now with the use of this technology with special reference to its efficacy and safety are presented.

About the Author

D N Laptev



References

1. Нaugstvedt A., Wentzel-Larsen T., Graue M., Søvik O., Rokne B. Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med 2010; 27: 1: 72-78.

2. Northam E.A., Anderson P.J., Jacobs R., Hughes M., Warne G.L., Werther G.A. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabet Care 2001; 24: 9: 1541-1546.

3. Gill G.V., Woodward A., Casson I.F., Weston P.J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes - the 'dead in bed' syndrome revisite. Diabetologia 2009; 52: 42-45.

4. Лаптев Д.Н., Рябыкина Г.В., Соболев А.В., Кириллов К.К., Сеид-Гусейнов А.А. Связь гликемии и длительности интервала QT с двигательной активностью у детей и подростков, больных сахарным диабетом 1-го типа. Пробл эндокринол 2010; 6: 56: 24-31.

5. Лаптев Д.Н., Рябыкина Г.В., Сеид-Гуссейнов А.А. Изменение длительности интервала QT у детей и подростков, больных сахарным диабетом 1-го типа. Кардиология 2007; 12: 35-38.

6. Campbell I.W. Dead in bed syndrome: a new manifestation of nocturnal hypoglycaemia? Diabet Med 1991; 8: 3-4.

7. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediat 1994; 125: 177-188.

8. Porter P.A., Keating B., Byrne G., Jones T.W. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. J Pediat 1997; 130: 339-341.

9. Ahmet A., Dagenais S., Barrowman N.J., Collins C.J., Lawson M.L. Prevalence of Nocturnal Hypoglycemia in Pediatric Type 1 Diabetes: A Pilot Study Using Continuous Glucose Monitoring. J Pediatr 2011.

10. Amin R., Ross K., Acerini C.L., Edge J.A., Warner J., Dunger D.B. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabet Care 2003; 26: 3: 662-667.

11. Albisser A.M., Leibel B.S. The artificial pancreas. Clin Endocrinol Metab 1977; 6: 457-479.

12. Hovorka R., Allen J.M., Elleri D. et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010; 375: 743-751.

13. Pickup J., Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabet Care 2002; 25: 593-598.

14. Bolinder J., Ungerstedt U., Arner P. Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia 1992; 35: 1177-1180.

15. Bode B.W., Gross T.M., Thornton K.R., Mastrototaro J.J. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabet Res Clin Pract 1999; 46: 183-190.

16. Attia N., Jones T.W., Holcombe J., Tamborlane W.V. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabet Care 1998; 21: 817-821.

17. Slover R.H., Welsh J.B., Criego A., Weinzimer S.A., Willi S.M., Wood M.A., Tamborlane W.V. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediat Diabet 2012; 13: 1: 6-11.

18. Choudhary P., Shin J., Wang Y., Evans M.L., Hammond P.J., Kerr D., Shaw J.A., Pickup J.C., Amiel S.A. Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia. Diabet Care 2011; 34: 9: 2023-2025.

19. Danne T., Kordonouri O., Holder M., Haberland H., Golembowski S., Remus K., Bläsig S., Wadien T., Zierow S., Hartmann R., Thomas A. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabet Technol Ther 2011; 13: 11: 1129-1134.

20. Agrawal P., Welsh J.B., Kannard B., Askari S., Yang Q., Kaufman F.R. Insulin Pump TherapyWith Automated Insulin Suspension in Response to Hypoglycemia. J Diabetes Sci Technol 2011; 5: 5: 1137-1141.


Review

For citations:


Laptev D.N. Insulin pump therapy with the function of automatic stopping delivery of insulin in response to hypoglycemia. Problems of Endocrinology. 2012;58(3):70-74. https://doi.org/10.14341/probl201258370-74

Views: 475


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)